Gossage on PED users in the Hall: "I really don't know what we'd do"


Goose Gossage.jpgSo earlier I asked if someone had Rich Gossage’s cell.
Seems someone did, and I just got off the phone with the Goose.  Nicest
guy in the world, by the way. If you’re going to talk to a Hall of Fame
reliever today, I highly recommend that you make it Gossage.

Anyway, the reason I called him was because I wanted to know, in light of his feelings on Mark McGwire and other steroid users,
what he’d think if Jose Canseco was proven right and we found out that
a current member of the Baseball Hall of Fame used performance
enhancing drugs. And Gossage was honest: he has no idea.

“I don’t really know what I’d do,” Gossage said.  “We’d have to find
out all the facts,” he said. “It’s a big dark cloud. I don’t know what
the scenario would look like.”

Gossage went on to say that it would probably depend on what the
writers did going forward with steroid users like Barry Bonds and Roger
Clemens — guys who are sure shot Hall of Famers if they hadn’t used. 
“If they let in some of those guys, I guess things are different.  What
I said about integrity yesterday still stands, but as for the Hall,
we’d have to see how the writers handled it. I can only speak for what
I believe.”

Gossage wouldn’t speculate about whether it would be appropriate to
remove someone from the Hall of Fame.  And though I didn’t ask him, he
volunteered that he has no idea what member, if any, could have
possibly used steroids, and doesn’t know one way or the other if anyone
had (he wouldn’t comment on the issue of Canseco’s credibility).

To date, no member of the Hall has ever been de-inducted, as it were,
and I could find nothing that suggests that the Hall even has a
procedure for doing so. Of course, if they wanted to, the Hall could
simply call a meeting of its board and make a rule in about five
minutes.  But let’s face it: if the Football Hall of Fame hasn’t taken
out O.J., what are the odds that the Baseball Hall of Fame would remove
a juicer?

But back to Gossage, who was gracious enough to chat with me a bit
longer than I thought he might:  He thinks that there’s a difference
between drugs of abuse and performance enhancing drugs.  He says “Dave
Parker was one of the top five baseball players I ever played with.” He
does not think that his — or Tim Raines or any other player’s —
cocaine use should be held against them in Hall of Fame voting. 
“Parker belongs,” he said. “What he did, with the cocaine, that
decreased his performance, it didn’t enhance it. If he hadn’t done that
stuff we wouldn’t be having this conversation.”  Gossage clearly thinks Parker would have been a first ballot Hall of Famer absent his mid-career cocaine-induced swoon.

“It all boils down to one word: integrity,” Gossage said.  “When it
comes to steroids, you have to talk about the records, and records are
something huge.  The home run record is the greatest record there is.”

I had to ask, of course: is Aaron still the home run king?  “In my mind
he is.  Not only was he the best. But look at where he came from. All
he did. That’s a Hall of Famer.”

I came away from our conversation with the impression that Goose
Gossage is a reasonable and level-headed guy when it comes to this
stuff. He believes what he believes, but he knows others disagree. 
He’s not out to moralize on the subject or tell others what to think.

It’s easy to get the opposite impression of the man, however, from
reading some of the reporting about him that we’ve seen in past couple
of years.  Some of that stuff has made him look like a fire-breather on
the subject of Hall of Fame standards in general and steroids in
particular. It’s enough to make one wonder if the writers who have
elicited all of those juicy quotes from him are trying to make him seem
more of a crusader than he really is.

To me he just seems sensible. But then again, he’s from Colorado, and I’ve never known anyone from Colorado who was anything but sensible.

Mariners interested in free agent outfielder Nori Aoki

AP Photo/Ben Margot
Leave a comment

New Mariners general manager Jerry Dipoto has kept pretty busy in his short time on the job and Bob Dutton of the Tacoma News Tribune reports that free agent outfielder Nori Aoki could be his next target. The club recently pursued a trade for Marlins outfielder Marcell Ozuna, but the asking price has them looking at alternatives.

Aoki, who turns 34 in January, has hit .287 with a .353 on-base percentage over four seasons since coming over from Japan. He was having a fine season with the Giants this year prior to being shut down in September with lingering concussion symptoms.

The Giants decided against picking up Aoki’s $5.5 million club option for 2016 earlier this month, but he should still do pretty well for himself this winter assuming he’s feeling good.

Report: Johnny Cueto is believed to be looking for a $140-160 million deal

AP Photo/Matt Slocum
Leave a comment

It was reported Sunday that free agent right-hander Johnny Cueto had turned down a six-year, $120 million contract from the Diamondbacks. He’s hoping to land a bigger deal this winter and ESPN’s Jerry Crasnick has heard some chatter about what he’s looking for.

Jordan Zimmermann finalized a five-year, $110 million contract with the Tigers today, which works out to $22 million per season. Arizona’s offer to Cueto checked in at $20 million per season. A six-year offer to Cueto at the same AAV (average annual value) as Zimmermann would put him at $132 million, which is still a little shy of the figure stated by Crasnick. Of course, Cueto owns a 2.71 ERA (145 ERA+) over the last five seasons compared to a 3.14 ERA (123 ERA+) by Zimmermann during that same timespan, so there’s a case to be made that he should get more. Still, he’s the clear No. 3 starter on the market behind David Price and Zack Greinke.

CBS Sports’ Jon Heyman reports that the Dodgers, Giants, Red Sox, and Cubs are among the other teams who have interest in Cueto. One variable in his favor is that he is not attached to draft pick compensation, as he was traded from the Reds to the Royals during the 2015 season.

Report: Around 20 teams have contacted the Braves about Shelby Miller

AP Photo/John Bazemore
Leave a comment

The rebuilding Braves have already been active on the trade market and they might not be done, as CBS Sports’ Jon Heyman reports that right-hander Shelby Miller has been a very popular name. In fact, around 20 teams have checked in.

Nothing is considered close and the Braves have set a very high asking price, mostly centered around offense. They asked for right-hander Luis Severino in talks with the Yankees and would expect outfielder Marcell Ozuna among other pieces from the Marlins. The Diamondbacks and Giants are among the other interested clubs.

Miller is under team control through 2018, so there’s not necessarily a sense of urgency to move him, but anything is possible with the way the Braves are doing things right now. The 25-year-old is coming off a year where he went 6-17, but that was about really rotten luck more than anything else, as he had a fine 3.02 ERA and 171/73 K/BB ratio over 205 1/3 innings. The Braves gave him the worst run support of any starter in the majors.

Mets expected to tender a contract to Jenrry Mejia

NEW YORK, NY - JULY 12:  Jenrry Mejia #58 of the New York Mets reacts as he walks off the field after getting the final out of the seventh inning against the Arizona Diamondbacks at Citi Field on July 12, 2015 in the Flushing neighborhood of the Queens borough of New York City.  (Photo by Jim McIsaac/Getty Images)
Photo by Jim McIsaac/Getty Images

Jenrry Mejia appeared in just seven games this past season due to a pair of suspensions for performance-enhancing drugs, but Adam Rubin of ESPN New York reports that the Mets are expected to tender him a contract for 2016.

While the Mets were vocal about their disappointment in Mejia’s actions, it makes sense to keep him around as an option. Had he played a full season in 2015, he would have earned $2.595 million. He’s arbitration-eligible for the second time this winter and figures to receive a contract similar to his 2015 figure, but he’ll only be paid for the games he plays. He still has 100 games to serve on his second PED suspension, which means that he’ll only be paid for 62 games in 2016. This likely puts his salary closer to $1 million, which is a small price to pay for someone who could prove useful during the second half and beyond. He also won’t count toward the team’s 40-man roster until he’s active.

Mejia, who turned 26 in October, owns a 3.68 ERA in the majors and saved 28 games for the Mets in 2014. He’s currently pitching as a starter in the Dominican Winter League.